Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Clearside BiomedicalInflarxXeris PharmaceuticalsIMMUTEP LTD/STrillium Therapeutics
SymbolNASDAQ:CLSDNASDAQ:IFRXNASDAQ:XERSNASDAQ:IMMPNASDAQ:TRIL
Price Information
Current Price$1.74$3.60$2.05$0.73$3.99
52 Week RangeBuyHoldBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$5.00$12.50$16.00$4.00$4.00
% Upside from Price Target187.36% upside247.22% upside680.49% upside451.12% upside0.25% upside
Trade Information
Market Cap$83.01 million$93.47 million$85.66 million$30.03 million$324.52 million
Beta0.82-1.50.461.392.28
Average Volume745,091993,859624,554521,7844,792,917
Sales & Book Value
Annual Revenue$2.17 millionN/A$2.72 million$5.36 million$120,000.00
Price / Sales35.98N/A28.325.282,731.82
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.25 per share$7.64 per share$0.53 per share$0.51 per share($0.86) per share
Price / Book6.96N/A3.871.42-4.64
Profitability
Net Income$-30,770,000.00$-35,210,000.00$-125,580,000.00$-13,120,000.00$-41,620,000.00
EPS($0.81)($1.40)($4.81)N/A($1.38)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-1,416.02%N/A-4,568.21%N/AN/A
Return on Equity (ROE)-246.61%-35.75%-209.32%N/AN/A
Return on Assets (ROA)-102.54%-32.84%-94.43%N/A-64.66%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.42%N/A4.04%0.29%N/A
Current Ratio2.31%7.81%3.20%6.77%1.72%
Quick Ratio2.31%7.81%3.12%4.44%1.72%
Ownership Information
Institutional Ownership Percentage17.72%19.53%46.94%0.30%30.45%
Insider Ownership Percentage10.60%N/A7.43%N/AN/A
Miscellaneous
Employees503690N/AN/A
Shares Outstanding44.87 million25.96 million37.57 million39.00 million82.16 million
Next Earnings Date5/13/2020 (Estimated)N/A5/14/2020 (Estimated)N/A5/11/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel